InsiderClue
← All stocks

VERACYTE, INC.

VCYT Net selling
CIK 0001384101 #1647 in the set updated 17 Sep 2026
Bought (120 mo)
$1.05M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$274.05M
$16.85M on a plan · $70.01M straight out of an exercise
Sold at will
$187.20M
77 of 353 sales
Net
−$273.00M
−$186.15M against sales at will

By person

30 insiders · 382 transactions
25.2×

Marc Stapley holds 25.2 times base salary in stock. $17.69M of shares against $700.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Marc Stapley last reported holding, valued at $40.95, the price Common Stock was last bought or sold at on the open market here, on 14 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
EASTHAM KARIN
Director
—
$149.91M (30)
−$149.91M
19,497
0.0243%
$798.39K
+10.6%
TREU JESSE I
Director
—
$26.86M (13)
−$26.86M
1,236,571
1.54%
$50.64M
−56.0%
Anderson Bonnie H
Director
—
$26.05M (66) scheduled
−$26.05M
396,606
0.4933%
$16.24M
+69.7%
JONES EVAN/ FA
Director
—
$12.28M (53)
−$12.28M
104,287
0.1297%
$4.27M
−75.1%
Kennedy Giulia C
Chief Scientific & Med Officer
—
$12.22M (53) scheduled
−$12.22M
65,970
0.0821%
$2.70M
+601.3%
Stapley Marc
Chief Executive Officer
$980.09K (1)
$11.15M (11) scheduled
−$10.17M
432,073
0.5375%
$17.69M
+7,904%
Hall Christopher M
President and COO
—
$6.66M (15) scheduled
−$6.66M
28,258
0.0352%
$1.16M
—
Hanna John Walter JR
Chief Commercial Officer
—
$6.47M (19) scheduled
−$6.47M
73,844
0.0919%
$3.02M
+10.3%
Kennedy Keith
COO / CFO
—
$4.22M (8) scheduled
−$4.22M
116,858
0.1454%
$4.79M
+1,131%
Chambers Rebecca
Chief Financial Officer
—
$2.82M (12) scheduled
−$2.82M
166,025
0.2065%
$6.80M
+9,113%
McGuire Annie
EVP, General Counsel
—
$2.74M (17) scheduled
−$2.74M
131,160
0.1632%
$5.37M
+8,535%
EPSTEIN ROBERT S
Director
—
$2.07M (6) scheduled
−$2.07M
57,718
0.0718%
$2.36M
—
Leite John
Global Chief Commercial Off
—
$1.92M (12) scheduled
−$1.92M
128,344
0.1597%
$5.26M
+209.5%
Wygant Jonathan
VP, Chief Accounting Officer
—
$1.80M (5) scheduled
−$1.80M
43,226
0.0538%
$1.77M
+174.5%
Febbo Phillip G.
Chief Scientific & Med Officer
—
$1.79M (7) scheduled
−$1.79M
133,048
0.1655%
$5.45M
—
GORDON KEVIN K
Director
—
$1.24M (5) scheduled
−$1.24M
8,720
0.0108%
$357.08K
—
Cohen Fred E
Director
—
$1.07M (2)
−$1.07M
10,000
0.0124%
$409.49K
—
Holstein Jens
Director
$70.39K (1)
$1.04M (9) scheduled
−$967.27K
27,471
0.0342%
$1.12M
—
Ho Mark
Principal Accounting Officer
—
$624.38K (1)
−$624.38K
71,728
0.0892%
$2.94M
+199.3%
BISHOP JOHN L
Director
—
$605.00K (2) scheduled
−$605.00K
33,125
0.0412%
$1.36M
—
Bhanji Muna
Director
—
$509.08K (7) scheduled
−$509.08K
42,718
0.0531%
$1.75M
—
KLEINER PERKINS CAUFIELD & BYERS XII, LLC entity
10% owner
—
—
—
2,801,929
3.49%
$114.74M
−21.1%
Nova Tina Susan
President, CLIA U.S.
—
—
—
76,988
0.0958%
$3.15M
+147.3%
Barr Eliav
Director
—
—
—
56,461
0.0702%
$2.31M
—
Haas Kevin Richard
Chief Dev and Tech Officer
—
—
—
44,221
0.0550%
$1.81M
—
Shafer David Brent
Director
—
—
—
31,100
0.0387%
$1.27M
—
Miller Thomas F.
Director
—
—
—
31,100
0.0387%
$1.27M
—
Alley Beverly Jane
VP, Corporate Controller
—
—
—
13,000
0.0162%
$532.34K
+73.3%
Erlinger III James H
EVP, General Counsel
—
—
—
7,500
0.0093%
$307.12K
—
Brooks Julie
EVP, Gen Counsel and Secretary
—
—
—
4,162
0.0052%
$170.43K
+10.0%

Individual transactions

107
Insider
Date
Role
Action
Shares
Price
Amount
Stapley Marc
4 Jun 2026
Chief Executive Officer
Sold after exercise
138,051
$50.12
$6.92M
Wygant Jonathan
22 May 2026
VP, Chief Accounting Officer
Sold after exercise
24,000
$45.40
$1.09M
EASTHAM KARIN
5 Dec 2025
Director
Sold after exercise
800
$46.59
$37.27K
EASTHAM KARIN
5 Dec 2025
Director
Sold after exercise
12,808
$45.84
$587.08K
EASTHAM KARIN
5 Dec 2025
Director
Sold after exercise
6,392
$44.52
$284.57K
JONES EVAN/ FA
5 Nov 2025
Director
Sold after exercise
657
$46.38
$30.47K
JONES EVAN/ FA
5 Nov 2025
Director
Sold after exercise
24,296
$45.73
$1.11M
JONES EVAN/ FA
5 Nov 2025
Director
Sold after exercise
5,872
$45.07
$264.64K
JONES EVAN/ FA
5 Nov 2025
Director
Sold after exercise
10,837
$43.80
$474.70K
JONES EVAN/ FA
5 Nov 2025
Director
Sold after exercise
1,126
$43.03
$48.46K
JONES EVAN/ FA
5 Nov 2025
Director
Sold after exercise
408
$41.74
$17.03K
EPSTEIN ROBERT S
1 Oct 2025
Director
Sold after exercise
21,473
$35.08
$753.20K
EASTHAM KARIN
2 Jan 2025
Director
Sold after exercise
4,691
$40.50
$190.00K
EASTHAM KARIN
2 Jan 2025
Director
Sold after exercise
5,309
$40.12
$213.01K
EPSTEIN ROBERT S
12 Nov 2024
Director
Sold after exercise
15,000
$38.32
$574.83K
JONES EVAN/ FA
13 Aug 2024
Director
Sold after exercise indirect
912
$32.77
$29.88K
JONES EVAN/ FA
13 Aug 2024
Director
Sold after exercise indirect
22,407
$32.36
$725.03K
JONES EVAN/ FA
13 Aug 2024
Director
Sold after exercise indirect
3,869
$31.19
$120.65K
JONES EVAN/ FA
13 Aug 2024
Director
Sold after exercise
688
$32.77
$22.54K
JONES EVAN/ FA
13 Aug 2024
Director
Sold after exercise
16,838
$32.36
$544.85K
JONES EVAN/ FA
13 Aug 2024
Director
Sold after exercise
2,931
$31.19
$91.41K
JONES EVAN/ FA
9 Aug 2024
Director
Sold after exercise indirect
746
$30.03
$22.40K
JONES EVAN/ FA
9 Aug 2024
Director
Sold after exercise
1,032
$30.03
$30.99K
JONES EVAN/ FA
7 Aug 2024
Director
Sold after exercise
5,108
$30.32
$154.88K
EASTHAM KARIN
7 Jun 2024
Director
Sold after exercise
2,500
$20.97
$52.43K
EASTHAM KARIN
1 Apr 2024
Director
Sold after exercise
10,000
$21.65
$216.53K
JONES EVAN/ FA
1 Mar 2024
Director
Sold after exercise
10,000
$24.36
$243.60K
BISHOP JOHN L
18 Jul 2023
Director
Sold after exercise
10,000
$30.50
$305.00K
BISHOP JOHN L
17 Jul 2023
Director
Sold after exercise
10,000
$30.00
$300.00K
Anderson Bonnie H
14 Apr 2023
Director
Sold after exercise
34,000
$22.04
$749.36K
EASTHAM KARIN
16 Mar 2023
Director
Sold after exercise
18,750
$22.78
$427.04K
Anderson Bonnie H
15 Mar 2023
Director
Sold after exercise
34,000
$22.76
$773.89K
EASTHAM KARIN
28 Feb 2023
Director
Sold after exercise
10,000
$25.00
$250.00K
Anderson Bonnie H
17 Jan 2023
Director
Sold after exercise
4,494
$26.64
$119.73K
Anderson Bonnie H
17 Jan 2023
Director
Sold after exercise
29,506
$26.30
$776.11K
Anderson Bonnie H
11 Jan 2023
Director
Sold after exercise
63,247
$25.13
$1.59M
Anderson Bonnie H
1 Dec 2022
Executive Chairwoman
Sold after exercise
45,460
$28.60
$1.30M
Anderson Bonnie H
1 Dec 2022
Executive Chairwoman
Sold after exercise
34,540
$27.81
$960.45K
Kennedy Giulia C
11 Nov 2022
Chief Scientific & Med Officer
Sold after exercise
2
$29.34
$58.68
Kennedy Giulia C
5 Aug 2022
Chief Scientific & Med Officer
Sold after exercise
1,028
$26.54
$27.28K
GORDON KEVIN K
8 Jun 2022
Director
Sold after exercise
15,000
$18.50
$277.50K
Kennedy Giulia C
4 Mar 2022
Chief Scientific & Med Officer
Sold after exercise
100
$26.49
$2.65K
Kennedy Giulia C
4 Mar 2022
Chief Scientific & Med Officer
Sold after exercise
5,844
$25.70
$150.19K
Kennedy Giulia C
4 Mar 2022
Chief Scientific & Med Officer
Sold after exercise
17,059
$24.91
$424.94K
EASTHAM KARIN
17 Dec 2021
Director
Sold after exercise
5,000
$45.00
$225.00K
Kennedy Giulia C
7 Dec 2021
Chief Scientific & Med Officer
Sold after exercise
1,750
$41.55
$72.71K
Kennedy Giulia C
7 Dec 2021
Chief Scientific & Med Officer
Sold after exercise
4,375
$39.69
$173.64K
Kennedy Giulia C
6 Dec 2021
Chief Scientific & Med Officer
Sold after exercise
1,785
$37.26
$66.51K
Kennedy Giulia C
6 Dec 2021
Chief Scientific & Med Officer
Sold after exercise
3,897
$36.11
$140.71K
Kennedy Giulia C
6 Dec 2021
Chief Scientific & Med Officer
Sold after exercise
3,550
$35.37
$125.56K
Kennedy Giulia C
7 Sep 2021
Chief Scientific & Med Officer
Sold after exercise
497
$51.23
$25.46K
Kennedy Giulia C
7 Sep 2021
Chief Scientific & Med Officer
Sold after exercise
12,034
$50.52
$607.95K
Kennedy Giulia C
23 Jun 2021
Chief Scientific & Med Officer
Sold after exercise
4,375
$39.75
$173.91K
Kennedy Giulia C
4 Jun 2021
Chief Scientific & Med Officer
Sold after exercise
4,979
$35.17
$175.11K
Kennedy Giulia C
4 Jun 2021
Chief Scientific & Med Officer
Sold after exercise
2,595
$34.39
$89.25K
Kennedy Giulia C
4 Jun 2021
Chief Scientific & Med Officer
Sold after exercise
1,507
$33.28
$50.15K
Kennedy Giulia C
4 Mar 2021
Chief Scientific & Med Officer
Sold after exercise
300
$55.49
$16.65K
Kennedy Giulia C
4 Mar 2021
Chief Scientific & Med Officer
Sold after exercise
1,431
$54.72
$78.31K
Kennedy Giulia C
4 Mar 2021
Chief Scientific & Med Officer
Sold after exercise
2,606
$53.50
$139.41K
Kennedy Giulia C
4 Mar 2021
Chief Scientific & Med Officer
Sold after exercise
5,032
$52.38
$263.56K
Kennedy Giulia C
4 Mar 2021
Chief Scientific & Med Officer
Sold after exercise
8,114
$51.38
$416.90K
Kennedy Giulia C
4 Mar 2021
Chief Scientific & Med Officer
Sold after exercise
2,819
$50.40
$142.07K
Kennedy Giulia C
4 Mar 2021
Chief Scientific & Med Officer
Sold after exercise
2,991
$49.22
$147.21K
Kennedy Giulia C
4 Mar 2021
Chief Scientific & Med Officer
Sold after exercise
8,483
$48.29
$409.61K
Kennedy Giulia C
4 Mar 2021
Chief Scientific & Med Officer
Sold after exercise
20,239
$47.11
$953.54K
EASTHAM KARIN
25 Feb 2021
Director
Sold after exercise
200
$61.77
$12.35K
EASTHAM KARIN
25 Feb 2021
Director
Sold after exercise
3,606
$61.09
$220.30K
EASTHAM KARIN
25 Feb 2021
Director
Sold after exercise
2,444
$60.03
$146.71K
Anderson Bonnie H
13 Jan 2021
Chairman and CEO
Sold after exercise
12,177
$51.26
$624.18K
Anderson Bonnie H
13 Jan 2021
Chairman and CEO
Sold after exercise
6,364
$50.64
$322.28K
Anderson Bonnie H
12 Jan 2021
Chairman and CEO
Sold after exercise
400
$51.20
$20.48K
Anderson Bonnie H
12 Jan 2021
Chairman and CEO
Sold after exercise
15,568
$50.29
$782.98K
Anderson Bonnie H
12 Jan 2021
Chairman and CEO
Sold after exercise
4,386
$49.77
$218.31K
Anderson Bonnie H
11 Jan 2021
Chairman and CEO
Sold after exercise
11,497
$51.56
$592.75K
Anderson Bonnie H
11 Jan 2021
Chairman and CEO
Sold after exercise
34,257
$50.90
$1.74M
Anderson Bonnie H
11 Jan 2021
Chairman and CEO
Sold after exercise
25,351
$49.81
$1.26M
GORDON KEVIN K
4 Jan 2021
Director
Sold after exercise
5,523
$49.27
$272.13K
GORDON KEVIN K
4 Jan 2021
Director
Sold after exercise
4,477
$48.62
$217.66K
Kennedy Giulia C
4 Dec 2020
Chief Scientific & Med Officer
Sold after exercise
6,094
$57.55
$350.73K
Kennedy Giulia C
4 Dec 2020
Chief Scientific & Med Officer
Sold after exercise
4,279
$56.86
$243.28K
Kennedy Giulia C
4 Dec 2020
Chief Scientific & Med Officer
Sold after exercise
3,642
$55.78
$203.14K
GORDON KEVIN K
12 Nov 2020
Director
Sold after exercise
1,806
$47.85
$86.42K
GORDON KEVIN K
12 Nov 2020
Director
Sold after exercise
8,194
$46.95
$384.72K
Hanna John Walter JR
6 Nov 2020
Chief Commercial Officer
Sold after exercise
1,200
$44.19
$53.03K
Hanna John Walter JR
6 Nov 2020
Chief Commercial Officer
Sold after exercise
20,050
$43.40
$870.08K
Hanna John Walter JR
5 Nov 2020
Chief Commercial Officer
Sold after exercise
133
$42.08
$5.60K
Hanna John Walter JR
5 Nov 2020
Chief Commercial Officer
Sold after exercise
2,660
$41.56
$110.55K
Hanna John Walter JR
5 Nov 2020
Chief Commercial Officer
Sold after exercise
3,613
$40.00
$144.51K
Anderson Bonnie H
8 Oct 2020
Chairman and CEO
Sold after exercise
50,000
$38.00
$1.90M
Kennedy Giulia C
6 Oct 2020
Chief Scientific & Med Officer
Sold after exercise
2,500
$35.21
$88.03K
Anderson Bonnie H
10 Sep 2020
Chairman and CEO
Sold after exercise
6,607
$31.47
$207.93K
Anderson Bonnie H
10 Sep 2020
Chairman and CEO
Sold after exercise
13,393
$30.61
$409.93K
Kennedy Giulia C
4 Sep 2020
Chief Scientific & Med Officer
Sold after exercise
2,141
$32.24
$69.02K
Kennedy Giulia C
4 Sep 2020
Chief Scientific & Med Officer
Sold after exercise
2,350
$31.21
$73.34K
Kennedy Giulia C
4 Sep 2020
Chief Scientific & Med Officer
Sold after exercise
2,536
$30.05
$76.21K
Hanna John Walter JR
31 Aug 2020
Chief Commercial Officer
Sold after exercise
473
$33.78
$15.98K
Hanna John Walter JR
31 Aug 2020
Chief Commercial Officer
Sold after exercise
55,970
$33.37
$1.87M
Hanna John Walter JR
21 Aug 2020
Chief Commercial Officer
Sold after exercise
1,400
$36.00
$50.41K
Kennedy Giulia C
31 Jul 2020
Chief Scientific & Med Officer
Sold after exercise
20,000
$35.33
$706.69K
Hanna John Walter JR
31 Jul 2020
Chief Commercial Officer
Sold after exercise
14,095
$36.12
$509.15K
Anderson Bonnie H
30 Jul 2020
Chairman and CEO
Sold after exercise
11,365
$32.24
$366.40K
Anderson Bonnie H
23 Jul 2020
Chairman and CEO
Sold after exercise
3,280
$32.04
$105.11K
Anderson Bonnie H
22 Jul 2020
Chairman and CEO
Sold after exercise
100
$32.00
$3.20K
Anderson Bonnie H
21 Jul 2020
Chairman and CEO
Sold after exercise
3,447
$32.09
$110.61K
Hanna John Walter JR
21 Jul 2020
Chief Commercial Officer
Sold after exercise
653
$32.36
$21.13K
Anderson Bonnie H
20 Jul 2020
Chairman and CEO
Sold after exercise
20,349
$32.04
$651.91K
Hanna John Walter JR
20 Jul 2020
Chief Commercial Officer
Sold after exercise
11,294
$32.05
$361.99K
Showing 250 of 382 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 492
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 84
Sales straight out of an exercise 192
Sales at will 77
Transactions with no price 0
Shares from compensation/vesting 7,377,221
Sales filed before the plan box existed 64
History held since 8 Dec 2016